LYTIR

Company · CATX

Perspective Therapeutics, Inc.

Nasdaq's symbol directory lists CATX on NYSE American as “Perspective Therapeutics, Inc. Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 8 occasions ($163K); insiders sold on 3 occasions ($488K); 8 filings by holders of 5% or more; 7 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 53

Insider purchases and sales, by month (last 12 months)Insider purchases: $163K in total; Insider sales: $488K in total.Aug: Insider sales $246KSep: Insider sales $243KNov: Insider purchases $163KDecJanFebMarAprMayJunJulAugSepOctNov$163K$246K
Insider purchases above the line: $163KInsider sales below: $488K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Lantheus Holdings, Inc. sold on 2 days latest Sep 1, 2026 sold $357K
  2. Lantheus Alpha Therapy, LLC sold on 1 day latest Sep 2, 2026 sold $131K
  3. Robert F. Williamson III bought on 2 days latest Nov 17, 2026 bought $42K
  4. Spoor Johan M., Chief Executive Officer bought on 1 day latest Nov 11, 2026 bought $38K
  5. Markus Puhlmann, Chief Medical Officer bought on 2 days latest Nov 12, 2026 bought $35K
  6. Frank Morich bought on 2 days latest Nov 16, 2026 bought $29K
  7. Lori A. Woods bought on 1 day latest Nov 12, 2026 bought $20K
Every trade (11)
  1. BUYRobert F. Williamson III bought Nov 17, 2026 25,000 shares filing $21K
  2. BUYFrank Morich bought Nov 16, 2026 15,000 shares filing $14K
  3. BUYMarkus Puhlmann, Chief Medical Officer bought Nov 12, 2026 35,000 shares filing $30K
  4. BUYRobert F. Williamson III bought Nov 12, 2026 24,898 shares 2 legs combined filing $21K
  5. BUYLori A. Woods bought Nov 12, 2026 23,750 shares filing $20K
  6. BUYFrank Morich bought Nov 12, 2026 15,000 shares filing $15K
  7. BUYSpoor Johan M., Chief Executive Officer bought Nov 11, 2026 47,000 shares filing $38K
  8. BUYMarkus Puhlmann, Chief Medical Officer bought Nov 11, 2026 6,000 shares filing $5K
  9. SELLLantheus Alpha Therapy, LLC sold Sep 2, 2026 42,129 shares filing $131K
  10. SELLLantheus Holdings, Inc. sold Sep 1, 2026 35,769 shares filing $112K
  11. SELLLantheus Holdings, Inc. sold Aug 31, 2026 78,145 shares filing $246K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Commodore Capital LP filed Nov 16, 2026 Schedule 13G/A passive filing 5.5%
  2. Lantheus Holdings, Inc. filed Nov 12, 2026 Schedule 13D/A may seek influence 4,739,011 shares filing 3.9%
  3. STATE STREET CORPORATION filed Nov 10, 2026 Schedule 13G passive 2,026,991 shares filing 1.8%
  4. Lantheus Holdings, Inc. filed Sep 23, 2026 Schedule 13D/A may seek influence 8,739,011 shares filing 7.7%
  5. Lantheus Holdings, Inc. filed Sep 4, 2026 Schedule 13D/A may seek influence 11,440,513 shares filing 10%
  6. Integrated Core Strategies (US) LLC filed Aug 13, 2026 Schedule 13G/A passive filing 5.5%
  7. STATE STREET CORPORATION filed Aug 7, 2026 Schedule 13G passive 6,051,771 shares filing 5.3%
  8. MILLENNIUM MANAGEMENT LLC filed Jul 20, 2026 Schedule 13G passive filing 5.3%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Other events filing Nov 9, 2026
  2. Other events filing Nov 6, 2026
  3. Other events filing Nov 6, 2026
  4. Other events filing Oct 23, 2026
  5. Other events filing Oct 8, 2026
  6. Other events filing Oct 1, 2026
  7. Other events filing Sep 14, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.